3E093BZ
3E093BZ — Introduction of Anesthetic Agent into Nose, Percutaneous Approach
Billable / specific codeICD-10-PCS
CMS abbreviated title: Introduction of Anesthetic Agent into Nose, Perc Approach
How 3E093BZ is built
Every ICD-10-PCS code is seven independent character positions. Each one is a separate decision, and the meaning of a character depends on the positions before it.
- 3SectionAdministration — What family of procedure this is
- EBody systemWhich system it acts on
- 0Root operationThe objective — the verb of the procedure
- 9Body partThe specific site
- 3ApproachHow the site was reached
- BDeviceWhat was left in place, if anything
- ZQualifierA further distinction where one applies
Codes near 3E093BZ
In CMS’s own ordering, which groups codes that differ by only the last character or two — usually the approach, device or qualifier.
- 3E083PZIntroduction of Platelet Inhibitor into Heart, Percutaneous Approach
- 3E084GCIntroduction of Other Therapeutic Substance into Heart, Percutaneous Endoscopic Approach
- 3E09305Introduction of Other Antineoplastic into Nose, Percutaneous Approach
- 3E0930MIntroduction of Antineoplastic, Monoclonal Antibody, into Nose, Percutaneous Approach
- 3E09328Introduction of Oxazolidinones into Nose, Percutaneous Approach
- 3E09329Introduction of Other Anti-infective into Nose, Percutaneous Approach
- 3E0933ZIntroduction of Anti-inflammatory into Nose, Percutaneous Approach
- 3E0934ZIntroduction of Serum, Toxoid and Vaccine into Nose, Percutaneous Approach
- 3E093BZIntroduction of Anesthetic Agent into Nose, Percutaneous Approach
- 3E093GCIntroduction of Other Therapeutic Substance into Nose, Percutaneous Approach
- 3E093HZIntroduction of Radioactive Substance into Nose, Percutaneous Approach
- 3E093KZIntroduction of Other Diagnostic Substance into Nose, Percutaneous Approach
- 3E093NZIntroduction of Analgesics, Hypnotics, Sedatives into Nose, Percutaneous Approach
- 3E093TZIntroduction of Destructive Agent into Nose, Percutaneous Approach
- 3E09705Introduction of Other Antineoplastic into Nose, Via Natural or Artificial Opening
- 3E0970MIntroduction of Antineoplastic, Monoclonal Antibody, into Nose, Via Natural or Artificial Opening
- 3E09728Introduction of Oxazolidinones into Nose, Via Natural or Artificial Opening